“allergan” Archives

in
Entry Author Date Location
SMA, Migraine Data Lead Neuro Highlights from AAN Meeting 05/07/19 National
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments 05/03/19 National
Acelity Sells to 3M in Deal Valued at $6.7 Billion, Ending IPO Plan 05/02/19 Texas
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More 04/19/19 National
San Antonio Wound-Care Company Eyes (Another) Initial Public Offering 04/18/19 Texas
Bio Roundup: Gottlieb Exits, Bristol Defends, Biogen Buys & More 03/08/19 National
Oyster Point Gets $93M To Clear Up Dry Eye With a Nasal Spray 02/26/19 New York
With New Data, Intercept On Track for First-Ever Approved NASH Drug 02/19/19 New York
San Antonio Life Science Business Acelity Cuts 260 Jobs in Texas, NC 02/11/19 Texas
Former Zavante Executive Tapped as Abide Therapeutics President 01/28/19 San Diego
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial 01/22/19 Boston
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More 01/11/19 National
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More 01/11/19 National
With $42M, Ex-Ignyta CEO Aims At Cancer Again With Startup, Erasca 12/18/18 San Diego
15 For ’19: Key Clinical Data to Watch For Next Year (Part 2) 12/18/18 National
To Cover Debts, Synergy Inks $200M Bankruptcy Sale to Bausch Health 12/12/18 New York
Bio Roundup: ASH Wrap, CRISPR Baby Fallout, Moderna’s Record IPO 12/07/18 National
Roche Gains Place in NASH Race with Purchase of Jecure Therapeutics 11/27/18 San Francisco
Mirum Pharmaceuticals Launches with $120M to Advance Liver Drugs 11/07/18 San Diego
Westlake Bio Unveils $320M Fund to Put Los Angeles on the Biotech Map 09/05/18 National
Bio Roundup: EpiPen Shortage, Bluebird’s Bet, Biotech IPOs & More 08/24/18 National
New Faces, Big Impact: Meet the Finalists For Xconomy’s Newcomer Award 08/07/18 Boston
Bio Roundup: Drug Prices, CRISPR Caveats, Rubius IPO Pop & More 07/20/18 National
Allergan’s Migraine-Reducing Pill Hits Study Goals, Heads to Phase 3 06/11/18 New York
Bio Roundup: IDO Fallout, Express Scripts Dumps Amgen, Isaly Out & More 05/04/18 National
Bio Roundup: Hope for Lungs, Bradner’s Complaint, FDA Nods & More 04/20/18 National
Bio Roundup: Biotech IPOs, Migraine Progress, Takeda Woos Shire & More 03/30/18 National
Racing Allergan, Biohaven Touts Migraine Drug Data, But Shares Sink 03/26/18 New York
Bio Roundup: Lung Cancer Questions, Migraine Races, HIV Battle & More 02/09/18 National
Ex-MAP Execs Start Xoc with Plans to Leapfrog New Migraine Drugs 02/07/18 San Francisco
Page 1 of 5 next page »